Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Simendan/adverse effects"'
Autor:
Gabriella Malfatto, Matti Kivikko, Veli-Pekka Harjola, Johann Altenberger, Finn Gustafsson, Piero Pollesello, Kristjan Karason, Zoltán Papp, Detlef Kindgen-Milles, Carsten Tschöpe, John Parissis, Gerhard Pölzl
Publikováno v:
Journal of Cardiovascular Pharmacology
Altenberger, J, Gustafsson, F, Harjola, V-P, Karason, K, Kindgen-Milles, D, Kivikko, M, Malfatto, G, Papp, Z, Parissis, J, Pollesello, P, Pölzl, G & Tschöpe, C 2018, ' Levosimendan in Acute and Advanced Heart Failure : An Appraisal of the Clinical Database and Evaluation of Its Therapeutic Applications ', Journal of Cardiovascular Pharmacology, vol. 71, no. 3, pp. 129-136 . https://doi.org/10.1097/FJC.0000000000000533
Altenberger, J, Gustafsson, F, Harjola, V-P, Karason, K, Kindgen-Milles, D, Kivikko, M, Malfatto, G, Papp, Z, Parissis, J, Pollesello, P, Pölzl, G & Tschöpe, C 2018, ' Levosimendan in Acute and Advanced Heart Failure : An Appraisal of the Clinical Database and Evaluation of Its Therapeutic Applications ', Journal of Cardiovascular Pharmacology, vol. 71, no. 3, pp. 129-136 . https://doi.org/10.1097/FJC.0000000000000533
The use of inotropes for correcting hemodynamic dysfunction in patients with congestive heart failure has been described over many decades. However, negative or insufficient data have been collected regarding the effects of cardiac glycosides, catech
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc67f375e178ff6586db68b5bb287804
http://hdl.handle.net/10138/234833
http://hdl.handle.net/10138/234833